Chemoinformaics analysis of 1,3-Bis(3,4-dihydroxyphenyl)prop-2-en-1-one
| Molecular Weight | 272.256 | nRot | 3 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 20 |
| Exact Molecular Weight | 272.068 | nRing | 2 |
| Solubility: LogS | -3.542 | nHRing | 0 |
| Solubility: LogP | 6.27 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 37.0615 |
| nHD | 4 | BPOL | 12.9065 |
| QED | 0.513 |
| Synth | 3.683 |
| Natural Product Likeliness | 2.17 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.719 |
| Pgp-sub | 0.489 |
| HIA | 0.023 |
| CACO-2 | -4.825 |
| MDCK | 0.0000119 |
| BBB | 0.006 |
| PPB | 0.91443 |
| VDSS | 1.183 |
| FU | 0.102355 |
| CYP1A2-inh | 0.474 |
| CYP1A2-sub | 0.658 |
| CYP2c19-inh | 0.966 |
| CYP2c19-sub | 0.097 |
| CYP2c9-inh | 0.923 |
| CYP2c9-sub | 0.948 |
| CYP2d6-inh | 0.893 |
| CYP2d6-sub | 0.42 |
| CYP3a4-inh | 0.623 |
| CYP3a4-sub | 0.177 |
| CL | 17.143 |
| T12 | 0.39 |
| hERG | 0.063 |
| Ames | 0.027 |
| ROA | 0.715 |
| SkinSen | 0.933 |
| Carcinogencity | 0.07 |
| EI | 0.495 |
| Respiratory | 0.893 |
| NR-Aromatase | 0.652 |
| Antiviral | No |
| Prediction | 0.784837 |